Medicare Enrolled
Dr. Kimball Woodward
Optician · West Nyack, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Woodward from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Woodward?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Woodward
Dr. Kimball Woodward is an optician specialist in West Nyack, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Woodward performed 44,427 Medicare services across 3,965 unique beneficiaries.
Between the years covered by Open Payments, Dr. Woodward received a total of $5,346 from 33 pharmaceutical and/or device companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Woodward is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 1% volume in NY
$5,346 industry payments
Medicare Practice Summary
Medicare Utilization ↗44,427
Medicare services
Top 1% in NY for optician
3,965
Unique beneficiaries
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,338 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Eye injection (Vabysmo/faricimab) An injection of faricimab-svoa, a medication administered in 0.1 mg doses. |
35,160 | $29 | $58 |
| Retinal imaging (OCT scan) This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye. |
2,632 | $36 | $174 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,711 | $114 | $235 |
| Injection, ranibizumab, 0.1 mg | 1,089 | $184 | $772 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
979 | $76 | $180 |
| Eye injection for retinal disease A procedure involving the administration of medication directly into the eye. |
914 | $104 | $402 |
| Comprehensive eye exam, established patient A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider. |
514 | $100 | $225 |
| Visual field test, extended A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam. |
316 | $55 | $200 |
| Pegcetacoplan intravitreal injection, 1 mg An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram. |
300 | $120 | $221 |
| Retinal photography (fundus photo) This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures. |
162 | $34 | $173 |
| Dexamethasone intravitreal implant injection An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye. |
140 | $159 | $429 |
| Optic nerve imaging (OCT scan) Imaging of the optic nerve. |
106 | $30 | $158 |
| Comprehensive eye exam, new patient A comprehensive examination of the visual system performed for a new patient. |
67 | $111 | $300 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
52 | $128 | $300 |
| Imaging of front third of eye Imaging of the front third of the eye. |
45 | $27 | $82 |
| Retinal angiography with dye injection This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body. |
38 | $132 | $300 |
| Eye drainage system examination An examination of the internal drainage system of the eye to assess how fluid flows and drains from the eye. |
37 | $25 | $71 |
| Eyelash removal with forceps This procedure involves the manual removal of eyelashes using forceps. It is a mechanical extraction method performed on the eyelid area. |
31 | $19 | $115 |
| Eye photography Photographic imaging of the interior structures of the eye. |
31 | $21 | $49 |
| Amniotic membrane placement on eye surface This procedure involves placing amniotic membrane on the surface of the eye to promote wound healing. |
26 | $1,306 | $2,738 |
| Eye exam, established patient, focused A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom. |
23 | $78 | $172 |
| Eye deviation and range of motion exam An examination to measure eye deviation and assess the range of motion of the eyes. |
22 | $57 | $143 |
| Retinal laser treatment for leaking blood vessels This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels. |
21 | $309 | $1,000 |
| Laser repair to improve eye fluid flow A laser procedure used to enhance the drainage of fluid within the eye. |
11 | $228 | $727 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$5,346
Total received (2018-2024)
Avg $764/year across 7 years
Top 22% in NY for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
301
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,346 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$849
2023
$496
2022
$735
2021
$859
2020
$711
2019
$1,039
2018
$656
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$192
Genentech USA, Inc.
$186
Alcon Vision LLC
$160
Bausch & Lomb Americas Inc.
$64
ABBVIE INC.
$52
Oyster Point Pharma, Inc.
$48
Regeneron Healthcare Solutions, Inc.
$38
SUN PHARMACEUTICAL INDUSTRIES INC.
$36
Apellis Pharmaceuticals, Inc.
$33
Thea Pharma Inc.
$21
Tarsus Pharmaceuticals, Inc.
$19
Top 3 companies account for 63.3% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$922
Allergan, Inc.
$721
Novartis Pharmaceuticals Corporation
$404
Alcon Vision LLC
$334
Regeneron Healthcare Solutions, Inc.
$331
Astellas Pharma US Inc
$303
Sun Pharmaceutical Industries Inc.
$265
TissueTech, Inc.
$255
Bausch & Lomb Americas Inc.
$252
Allergan Inc.
$218
Shire North American Group Inc
$165
Spark Therapeutics, Inc.
$145
AbbVie Inc.
$117
Kala Pharmaceuticals, Inc.
$116
ABBVIE INC.
$100
Oyster Point Pharma, Inc.
$87
Aerie Pharmaceuticals, Inc.
$80
NOVARTIS PHARMACEUTICALS CORPORATION
$76
Bausch & Lomb, a division of Bausch Health US, LLC
$73
SUN PHARMACEUTICAL INDUSTRIES INC.
$66
Mallinckrodt Hospital Products Inc.
$43
Dompe US, Inc.
$37
Coherus Biosciences Inc.
$36
Apellis Pharmaceuticals, Inc.
$33
Mallinckrodt Enterprises LLC
$23
Thea Pharma Inc.
$21
GENZYME CORPORATION
$20
BIOTISSUE HOLDINGS, INC.
$19
TISSUETECH, INC.
$19
Tarsus Pharmaceuticals, Inc.
$19
Horizon Therapeutics plc
$16
Alimera Sciences, Inc.
$15
ThromboGenics, Inc.
$15
Top 3 companies account for 38.3% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROMSITE · CEQUA · COMBIGAN · Cequa · Cimerli · DURYSTA · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · EYSUVIS · FABRAZYME · INVELTYS · IYUZEH · Iluvien · Izervay · Jetrea · LOTEMAX SM · LUMIGAN · LUXTURNA · Lucentis · OXERVATE · OZURDEX · PROKERA · Prokera · RESTASIS · RESTASIS MULTIDOSE · Rhopressa · Rocklatan · STELLARIS PC · SUSVIMO · Simbrinza · Syfovre · TEPEZZA · TRAVATAN Z · TYRVAYA · VABYSMO · VYZULTA · Vabysmo · XDEMVY · XELPROS · XIIDRA · XIPERE · rhopressa · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
5,820
Per 100K population
1717.1
County median income
$110,631
Nearest hospital
NYACK HOSPITAL
2.5 mi
2.5 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Woodward is a mixed practice specialist, with above-average Medicare volume (top 1% in NY), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Woodward experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Woodward performed 35,160 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Woodward receive payments from pharmaceutical companies?
Yes. Dr. Woodward received a total of $5,346 from 33 companies across 301 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Woodward's costs compare to other opticians in West Nyack?
Dr. Woodward's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Woodward) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in West Nyack
Browse opticians in West Nyack ranked by procedure volume and transparency data.
Highest volume
Top Opticians in NY
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in NY
Which NY opticians receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Allergan, Inc. Payments to Doctors
See all physicians who received payments from Allergan, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology